Randox Laboratories
Bosch Healthcare Solutions, Randox Laboratories Develop Coronavirus Test
The test, developed by the firms in six weeks, is part of a viral respiratory panel and runs on Bosch's point-of-care Vivalytic system.
Randox Laboratories STI Assay Gets CE Mark
The assay detects 10 STIs and is performed on the molecular point-of-care Vivalytic platform, which was codeveloped by German company Bosch.
The company cites flexibility and ease of use as its main selling points, and is partnering with IVD firms like Randox and R-Biopharm on assay development.
New Protein Marker Could Enable Five-Fold Increase in Stroke Patients Eligible for rt-PA Therapy
Premium
University of Geneva researchers in collaboration with the UK's Proteome Sciences have identified a protein marker that could help doctors better determine the time of stroke onset.
Proteome Sciences Inks Stroke Biomarker Licensing Deal with Randox
NEW YORK (GenomeWeb News) – Proteome Sciences said today that it has signed a non-exclusive license with Randox Laboratories for use of its stroke protein biomarker portfolio.
Jan 24, 2012
Dec 6, 2011
May 31, 2011
May 17, 2011
New Product Watch: May 17, 2011
Premium
Sep 14, 2010
Aug 17, 2010
New Product Watch: Aug 17, 2010
Premium
Dec 1, 2009
New Product Watch: Dec 1, 2009
Premium
Oct 27, 2009
New Product Watch: Oct 27, 2009
Premium
Oct 13, 2009
New Product Watch: Oct 13, 2009
Premium
Mar 31, 2009